S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
NASDAQ:EXEL

Exelixis Earnings Date, Estimates, & History

$16.79
-0.12 (-0.71%)
(As of 11/30/2021 04:00 PM ET)
Add
Compare
Today's Range
$16.41
$16.99
50-Day Range
$16.79
$21.88
52-Week Range
$16.19
$25.77
Volume
2.45 million shs
Average Volume
2.05 million shs
Market Capitalization
$5.31 billion
P/E Ratio
32.92
Dividend Yield
N/A
Beta
0.94

Earnings Summary

Upcoming
Earnings Date
Feb. 9
Estimated

Actual EPS
(Nov. 2)
$0.12
Missed By -$0.07

Consensus EPS
(Nov. 2)
$0.19

Last Year's Q4 EPS
(11/5/2020)
-$0.10

Skip Charts & View Estimated and Actual Earnings Data

Exelixis Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Exelixis Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Exelixis (NASDAQ:EXEL) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20215$0.02$0.27$0.13 
Q2 20215$0.05$0.28$0.16 
Q3 20216$0.11$0.31$0.23 
Q4 20214$0.03$0.36$0.20 
FY 202120$0.21$1.22$0.72
Q1 20221$0.17$0.17$0.17 
Q2 20221$0.20$0.20$0.20 
Q3 20221$0.33$0.33$0.33 
Q4 20221$0.36$0.36$0.36 
FY 20224$1.06$1.06$1.06

EXEL Earnings Information

Exelixis last announced its quarterly earnings results on November 2nd, 2021. The biotechnology company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by $0.07. Exelixis has generated $0.51 earnings per share over the last year ($0.51 diluted earnings per share) and currently has a price-to-earnings ratio of 32.9. Earnings for Exelixis are expected to grow by 48.98% in the coming year, from $0.49 to $0.73 per share. Exelixis has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 9th, 2022 based off prior year's report dates.

Exelixis (NASDAQ:EXEL) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
2/9/2022
(Estimated)
        
11/2/20219/30/2021$0.19$0.12($0.07)$0.12    
8/5/20216/30/2021$0.05$0.30+$0.25$0.30$296.31 million$385.18 million      
5/6/20213/31/2021$0.04$0.09+$0.05$265.04 million$270.23 million  
2/9/202112/31/2020$0.05$0.09+$0.04$0.09$261.44 million$270.10 million  
11/5/20209/30/2020$0.01($0.10)($0.11)($0.10)$215.40 million$231.10 million    
8/6/20206/30/2020$0.12$0.21+$0.09$0.21$226.40 million$259.50 million  
5/5/20203/31/2020$0.13$0.1539+$0.0239$0.15$216.64 million$226.90 million    
2/25/2020Q4 2019$0.15$0.22+$0.07$0.22$240.49 million$240.31 million    
10/30/2019Q3 2019$0.19$0.31+$0.12$0.31$228.17 million$271.70 million  
7/31/2019Q2$0.23$0.25+$0.02$0.25$226.97 million$240.28 million    
5/1/20193/31/2019$0.24$0.24$0.24$206.06 million$215.49 million    
2/12/201912/31/2018$0.23$0.3710+$0.1410($0.41)$188.44 million$228.60 million  
11/1/20189/30/2018$0.19$0.41+$0.22$0.41$174.14 million$225.40 million    
8/1/2018Q2 2018$0.16$0.28+$0.12$0.28$157.37 million$186.10 million
5/2/2018Q1 2018$0.16$0.37+$0.21$0.37$146.39 million$212.35 million  
2/26/2018Q4 2017$0.12$0.12$0.12$120.25 million$120.10 million    
11/1/2017Q3 2017$0.08$0.26+$0.18$0.26$104.91 million$152.50 million
8/2/2017Q2 2017$0.04$0.06+$0.02$0.10$85.27 million$99.01 million  
5/1/2017Q1 2017($0.0090)$0.05+$0.0590$0.05$65.23 million$80.90 million  
2/27/2017Q416($0.01)$0.12+$0.13$0.12$64.88 million$77.58 million  
11/3/2016Q316($0.13)($0.04)+$0.09$0.06$43.15 million$62.19 million
8/3/2016Q216($0.27)($0.16)+$0.11($0.16)$16.76 million$36.25 million  
5/4/2016Q116($0.25)($0.27)($0.02)($0.27)$9.11 million$15.40 million  
2/29/2016Q415($0.22)($0.19)+$0.03($0.19)$8.16 million$9.94 million  
11/10/2015Q315($0.20)($0.22)($0.02)($0.22)$9.08 million$9.85 million  
8/11/2015Q215($0.21)($0.22)($0.01)($0.22)$8.69 million$8.00 million  
4/30/2015Q115($0.24)($0.18)+$0.06($0.18)$8.08 million$9.40 million  
2/24/2015Q414($0.31)($0.30)+$0.01($0.30)$7.50 million$7.35 million  
11/4/2014Q314($0.37)($0.32)+$0.05($0.28)$6.77 million$6.30 million  
7/31/2014Q214($0.39)($0.38)+$0.01($0.38)$5.66 million$6.56 million  
5/1/2014Q114($0.37)($0.39)($0.02)($0.39)$6.11 million$4.90 million  
2/20/2014Q4 2013($0.38)($0.38)($0.38)$5.71 million$4.34 million  
10/30/2013Q3 2013($0.38)($0.36)+$0.02($0.36)$5.55 million$5.50 million  
8/6/2013Q2 2013($0.30)($0.34)($0.04)($0.34)$6.55 million$11.90 million  
5/7/2013Q1 2013($0.27)($0.24)+$0.03($0.24)$5.33 million$9.70 million  
2/21/2013Q4 2012($0.24)($0.28)($0.04)$9.46 million$7.80 million  
11/7/2012Q312($0.30)($0.20)+$0.10$9.22 million$13.30 million
8/2/2012($0.27)($0.25)+$0.02
5/3/2012($0.19)($0.18)+$0.01
2/8/2012Q4 2011($0.13)$0.37+$0.50$0.39
10/27/2011$0.57$0.60+$0.03
8/4/2011($0.17)($0.16)+$0.01  
5/3/2011($0.19)($0.24)($0.05)
2/22/2011($0.21)($0.16)+$0.05  
11/4/2010Q3 2010($0.06)($0.08)($0.02)($0.08)
8/5/2010Q2 2010($0.17)($0.12)+$0.05($0.03)
5/11/2010Q1 2010($0.31)($0.25)+$0.06($0.10)
3/9/2010Q4 2009($0.27)($0.25)+$0.02($0.23)
10/29/2009Q3 2009($0.33)($0.22)+$0.11($0.20)
7/30/2009Q2 2009($0.41)($0.33)+$0.08($0.24)
5/7/2009Q1 2009($0.31)($0.36)($0.05)($0.38)
3/4/2009Q4 2008($0.35)($0.36)($0.01)($0.36)
10/27/2008Q3 2008($0.41)($0.39)+$0.02($0.41)
8/5/2008Q2 2008($0.39)($0.43)($0.04)($0.43)
5/6/2008Q1 2008($0.37)($0.39)($0.02)($0.39)
2/14/2008Q4 2007($0.28)($0.30)($0.02)($0.41)
(Earnings results data provided by Zacks Investment Research)












Exelixis (NASDAQ:EXEL) Earnings Frequently Asked Questions

When is Exelixis's earnings date?

Exelixis has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 9th, 2022 based off last year's report dates. Learn more on EXEL's earnings history

Did Exelixis beat their earnings estimates last quarter?

In the previous quarter, Exelixis (NASDAQ:EXEL) missed the analysts' consensus estimate of $0.19 by $0.07 with a reported earnings per share (EPS) of $0.12. Learn more on EXEL's earnings details

How can I listen to Exelixis's earnings conference call?

The conference call for Exelixis's latest earnings report can be listened to online. Listen to Conference Call

How can I read Exelixis's conference call transcript?

The conference call transcript for Exelixis's latest earnings report can be read online. Read Transcript

How much revenue does Exelixis generate each year?

Exelixis (NASDAQ:EXEL) has a recorded annual revenue of $987.54 million.

How much profit does Exelixis generate each year?

Exelixis (NASDAQ:EXEL) has a recorded net income of $111.78 million. EXEL has generated $0.51 earnings per share over the last four quarters.

What is Exelixis's price-to-earnings ratio?

Exelixis (NASDAQ:EXEL) has a trailing price-to-earnings ratio of 32.92 and a forward price-to-earnings ratio of 34.27. The price/earnings-to-growth ratio is 0.79.

What is Exelixis's EPS forecast for next year?

Exelixis's earnings are expected to grow from $0.49 per share to $0.73 per share in the next year, which is a 48.98% increase.

This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.